Webinar Overview: Choosing the Right CD34+ Stem Cell Mobilization Strategy
Hematopoietic stem cells (HSC, i.e., CD34+ stem cells) have unique properties that make them extraordinarily valuable in cell and gene therapy development. However, with multiple methods of cell mobilization and collection available, it’s important to know which one will provide the right yield and quality for your program’s success.
In this webinar we cover what those available methods are, their key differences, and how those differences could affect the development of your cell or gene therapy.
View to learn:
- A comparison of CD34+ stem cells derived from mobilized leukopaks, bone marrow, and cord blood
- How donor characteristics and different dosing regimens impact CD34+ stem cell yield
- How to minimize the impact of undesired cell types on CD34+ stem cell quality
- Donor tolerability with respect to different mobilization regimens
Webinar Presenters
Edward P. Scott, BS, MD
Principal
Factotum Consulting
Lanu Stoddart, MD
Medical Director
Charles River